Efficacy of etanercept for wear debris-induced osteolysis.
about
Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationLead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency.In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic miceElevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent MiceTranscription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafBThe effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.Role of direct estrogen receptor signaling in wear particle-induced osteolysis.Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions.A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activationEmerging ideas: can erythromycin reduce the risk of aseptic loosening?Actin and ERK1/2-CEBPβ signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells.Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model.Oestrogen deficiency modulates particle-induced osteolysisAseptic loosening.Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application.Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening.Lentivirus-mediated short hairpin RNA interference targeting TNF-alpha in macrophages inhibits particle-induced inflammation and osteolysis in vitro and in vivoInhibiting wear particles-induced osteolysis with naringin.Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model.The central role of wear debris in periprosthetic osteolysis.Inflammation, fracture and bone repair.TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings.Alternative macrophage activation in periprosthetic osteolysis.New animal models of wear-particle osteolysis.Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research.A novel strontium-doped calcium polyphosphate/erythromycin/poly(vinyl alcohol) composite for bone tissue engineering.Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation.Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages.Synergistic effects of mixed TiAlV and polyethylene wear particles on TNFalpha response in THP-1 macrophages.The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.Statins attenuate polymethylmethacrylate-mediated monocyte activation.Inhibiting wear particles-induced osteolysis with doxycycline.Low-dose captopril inhibits wear debris-induced inflammatory osteolysis.
P2860
Q24796088-0A85333C-974D-4370-AC85-0980F3F3AB7BQ24813247-3BA57AB1-CCF8-4DC2-B4BC-03426E29673EQ28383687-D123FA39-9041-4159-B01A-93487004CB57Q28396525-A88A3150-3B9F-421D-B9D1-DE5BC208919FQ28506372-0516D43D-9547-44C3-B6C1-303528AC7926Q33458930-A533A7AD-3E46-404D-8284-8CB4B60EA72BQ33670586-53F7DC71-2399-4D08-A439-1EE4D6AA890DQ34751110-63DAA47A-F733-4076-8F8A-647DDE6EF967Q34999751-4A48E2C2-43D3-4703-98B4-38CC9DB328A8Q35078775-C8052F4E-3024-4AA7-9446-58BB575C313DQ35344783-7D90C193-B9B1-44F5-9D11-06E5AE0B11BEQ35557415-149EF303-E271-484E-8EFE-EA16AB08409AQ35557947-E006FFA1-1B68-41F9-B66E-CD5D24ABF9F5Q35629551-4439A73B-4D65-4CAE-8F60-607458A20247Q35656883-61D8084A-44E2-407A-B87E-D98BBE0DBCFCQ35908576-E83B44D0-FD11-41F3-8025-A0B1735D5308Q36166825-93062CE5-BAFF-4CB0-97A6-8394549C375FQ36495023-8213D9C0-E07E-46EC-998E-85BA3D21BC7DQ36795335-AB246CCE-9659-4D2D-9B81-71F4EA8BC53DQ36796472-4F24AA9B-4AC5-4980-A428-3282AD6E27C6Q36803719-34D0F497-FFD4-42C3-97E8-AF4785A7347CQ36809157-999F83E0-7D75-4E89-90D9-A91BFEF2F0E6Q36942951-E16E30F2-DD98-4E95-99BD-D6CA66EFB8A5Q37118773-46565EC5-41F7-4C1C-A0CB-6A2A6E96BCD1Q37808661-3BF6D142-354A-4E53-8581-7DFDDE4F0731Q38044786-951DD853-8E0A-40CE-A850-0A3DCBDFC66DQ38148877-8E05835C-BCEF-4B68-9D12-25AA8F2564D0Q38211743-1B4EEA16-FE9E-4978-830A-BD0B8E5A52E8Q39533226-85AE3156-80F2-4881-AA88-75F231A49E9AQ39842640-060FCA00-1AA6-47A7-BE50-DCA5BC36BB5FQ40149808-8AF57AE8-AB41-4938-A1BF-C5C01BBF656FQ40199302-EAB3CCC5-7183-49AB-9428-9BE1DDD66646Q40711940-C6FADF75-127C-4B8E-9A38-C02F6381A8E1Q41883420-CC2DA89A-8703-4A62-A776-5ED64B0C18D2Q42523628-DB7DAAF3-8451-41D9-9103-762756C451A5Q42562661-55A45796-1D51-4D2F-AAFF-405AD7B1B1E9Q46108924-0F1A041B-945D-498B-B2E1-38C978138F5EQ46746313-8C9AB1F7-3249-4B9B-974A-659C8E0AFF1CQ46990199-543912AE-4C2F-4AB2-86A8-BC51E7130185Q54355518-63D36A3B-623E-42EB-A148-0906C35B3E14
P2860
Efficacy of etanercept for wear debris-induced osteolysis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Efficacy of etanercept for wear debris-induced osteolysis.
@en
type
label
Efficacy of etanercept for wear debris-induced osteolysis.
@en
prefLabel
Efficacy of etanercept for wear debris-induced osteolysis.
@en
P2093
P1476
Efficacy of etanercept for wear debris-induced osteolysis.
@en
P2093
P304
P356
10.1359/JBMR.2001.16.2.338
P577
2001-02-01T00:00:00Z